Drug intelligence / Profile preview

GeloProsed

Development stage
Unknown
Lead developer
Pohl-Boskamp
Modality
Small Molecules
Administration
Oral
01

Overview

GeloProsed is a marketed pharmaceutical combination product developed by G. Pohl-Boskamp for the symptomatic relief of colds and flu-like infections. It contains two active ingredients: paracetamol (1000 mg), which acts as an analgesic and antipyretic, and phenylephrine hydrochloride (12.2 mg), which serves as a sympathomimetic decongestant. The product is uniquely formulated as a powder for oral administration that dissolves directly in the mouth without the need for water, facilitating convenient use. It is indicated for adults and adolescents aged 12 years and older to treat symptoms such as pain, headache, sore throat, and fever, particularly when accompanied by nasal congestion. Although G. Pohl-Boskamp is well-known for herbal medicines, GeloProsed is a conventional small-molecule pharmaceutical product.

Brand names
GeloProsed
02

Targets

ADRA1A (α1A)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on GeloProsed.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GeloProsed.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call